6101 - 6150 of 9148 Results
Title
Year
- Resource translocation drives 13C fractionation during recovery from disturbance in giant kelp, Macrocystis pyrifera2013RESTRICTEDTitle: Resource translocation drives 13C fractionation during recovery from disturbance in giant kelp, Macrocystis pyriferaJournal Name: Journal of PhycologyPublisher: WileyVol: 49Issue #: 5Start Page: 811End Page: 815Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/jpy.12099Citation Count: 21
- Patient Perspectives on Deep Brain Stimulation Clinical Research in Early Stage Parkinson’s Disease2016OPENTitle: Patient Perspectives on Deep Brain Stimulation Clinical Research in Early Stage Parkinson’s DiseaseJournal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol: 7Issue #: 1Start Page: 89End Page: 94Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3233/jpd-161031Citation Count: 15
-
OPENTitle: Use of an Online Portal to Facilitate Clinical Trial Recruitment: A Preliminary Analysis of Fox Trial FinderJournal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol: 5Issue #: 1Start Page: 55End Page: 66Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-140522Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd140522?id=journal-of-parkinsons-disease%2Fjpd140522Citation Count: 14
-
OPENTitle: Patient-Centered Identification of Meaningful Regulatory Endpoints for Medical Devices to Treat Parkinson’s DiseaseJournal Name: MDM Policy & PracticePublisher: SAGE PublicationsVol: 6Issue #: 1Start Page: 23814683211021380End Page: 23814683211021380Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1177/23814683211021380Best OA location URL: https://journals.sagepub.com/doi/pdf/10.1177/23814683211021380Citation Count: 14
-
OPENTitle: Putting participants and study partners FIRST when clinical trials end earlyJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 18Issue #: 12Start Page: 2736End Page: 2746Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/alz.12732Best OA location URL: https://doi.org/10.1002/alz.12732Citation Count: 12
-
OPENTitle: Use of Bayesian decision analysis to maximize value in patient-centered randomized clinical trials in Parkinson’s diseaseJournal Name: Journal of Biopharmaceutical StatisticsPublisher: Informa UK LimitedVol: 35Issue #: 5Start Page: 981End Page: 1000Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1080/10543406.2023.2170400Best OA location URL: https://doi.org/10.1080/10543406.2023.2170400Citation Count: 8
- Addition of Filgrastim (Neupogen) for Clozapine Rechallenge in the Case of Parkinson Disease Patient2017RESTRICTEDTitle: Addition of Filgrastim (Neupogen) for Clozapine Rechallenge in the Case of Parkinson Disease PatientJournal Name: Clinical NeuropharmacologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 40Issue #: 5Start Page: 233End Page: 234Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1097/wnf.0000000000000230Citation Count: 7
- Including People with Parkinson’s Disease in Clinical Study Design and Execution: A Call to Action2022OPENTitle: Including People with Parkinson’s Disease in Clinical Study Design and Execution: A Call to ActionJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 12Issue #: 4Start Page: 1359End Page: 1363Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-223190Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd223190?id=journal-of-parkinsons-disease%2Fjpd223190Citation Count: 15
-
OPENTitle: A Coalition to Advance Treatments for Parkinson’s Disease, Dementia with Lewy Bodies, and Related DisordersJournal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol: 14Issue #: 6Start Page: 1105End Page: 1114Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-230257Best OA location URL: https://doi.org/10.3233/jpd-230257Citation Count: 5
-
OPENTitle: Design considerations for C9orf72 disease prevention trialsJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 148Issue #: 11Start Page: 3844End Page: 3855Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/brain/awaf290Best OA location URL: https://academic.oup.com/brain/advance-article-pdf/doi/10.1093/brain/awaf290/63960980/awaf290.pdfCitation Count: 2
-
OPENTitle: Lack of replication of thirteen single-nucleotide polymorphisms implicated in Parkinson's disease: a large-scale international studyJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 5Issue #: 11Start Page: 917End Page: 923Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(06)70579-8Best OA location URL: http://orbilu.uni.lu/handle/10993/17148Citation Count: 82
- Oxidative Damage in Parkinson's Disease2005RESTRICTEDTitle: Oxidative Damage in Parkinson's DiseaseJournal Name: Antioxidants & Redox SignalingPublisher: SAGE PublicationsVol: 7Issue #: 5-6Start Page: 627End Page: 629Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1089/ars.2005.7.627Citation Count: 27
- Parkinson’s Progression Markers Initiative (PPMI) Online expands biomarker research in Parkinson’s disease (PD) (P9-11.006)2022RESTRICTEDTitle: Parkinson’s Progression Markers Initiative (PPMI) Online expands biomarker research in Parkinson’s disease (PD) (P9-11.006)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 98Issue #: 18_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.98.18_supplement.1529Citation Count: 5
-
OPENTitle: Dystrophin-associated protein scaffolding in brain requires α-dystrobrevinJournal Name: NeuroReportPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 21Issue #: 10Start Page: 695End Page: 699Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1097/wnr.0b013e32833b0a3bBest OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/2889226Citation Count: 15
-
OPENTitle: Review of the Effects of Lifestyle Modification on Parkinson’s DiseaseJournal Name: American Journal of Lifestyle MedicinePublisher: SAGE PublicationsVol:Issue #:Start Page: 15598276251384591End Page: 15598276251384591Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1177/15598276251384591Best OA location URL: https://journals.sagepub.com/doi/pdf/10.1177/15598276251384591?download=trueCitation Count: 2
-
OPENTitle: Increasing Efficiency of Recruitment in Early Parkinson’s Disease Trials: A Case Study Examination of the STEADY-PD III TrialJournal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol: 7Issue #: 4Start Page: 685End Page: 693Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-171199Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd171199?id=journal-of-parkinsons-disease%2Fjpd171199Citation Count: 20
- Biomarkers in Parkinson‘s Disease: A Funder‘s Perspective2010RESTRICTEDTitle: Biomarkers in Parkinson‘s Disease: A Funder‘s PerspectiveJournal Name: Biomarkers in MedicinePublisher: Informa UK LimitedVol: 4Issue #: 5Start Page: 723End Page: 729Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.2217/bmm.10.89Citation Count: 16
-
OPENTitle: Initiation of antidepressant medication and risk of incident stroke: using the Adult Changes in Thought cohort to address time-varying confoundingJournal Name: Annals of EpidemiologyPublisher: Elsevier BVVol: 35Issue #:Start Page: 42End Page: 47.e1Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.annepidem.2019.04.010Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8074509Citation Count: 13
- Pimavanserin for Psychotic Symptoms in People With Parkinsonism: A Second Chart Review2018RESTRICTEDTitle: Pimavanserin for Psychotic Symptoms in People With Parkinsonism: A Second Chart ReviewJournal Name: Clinical NeuropharmacologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 41Issue #: 5Start Page: 156End Page: 159Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1097/wnf.0000000000000296Citation Count: 12
- Human Peripheral Blood Neutrophil Isolation for Interrogating the Parkinson's Associated LRRK2 Kinase Pathway by Assessing Rab10 Phosphorylation2020OPENTitle: Human Peripheral Blood Neutrophil Isolation for Interrogating the Parkinson's Associated LRRK2 Kinase Pathway by Assessing Rab10 PhosphorylationJournal Name: Journal of Visualized ExperimentsPublisher: MyJove CorporationVol:Issue #: 157Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3791/58956Citation Count: 12
-
OPENTitle: Forecasts for the Attainment of Major Research Milestones in Parkinson’s DiseaseJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 10Issue #: 3Start Page: 1047End Page: 1055Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3233/jpd-201933Best OA location URL: https://doi.org/10.17863/cam.52302Citation Count: 4
-
OPENTitle: The Michael J. Fox Foundation’s Strategies for Accelerating Translation of LRRK2 into Therapies for Parkinson DiseaseJournal Name: CellsPublisher: MDPI AGVol: 9Issue #: 8Start Page: 1878End Page: 1878Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/cells9081878Best OA location URL: https://www.mdpi.com/2073-4409/9/8/1878/pdf?version=1597644425Citation Count: 6
-
OPENTitle: Parkinson’S Disease is Ready for Precision MedicineJournal Name: Personalized MedicinePublisher: Informa UK LimitedVol: 13Issue #: 5Start Page: 405End Page: 407Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.2217/pme-2016-0052Best OA location URL: https://www.futuremedicine.com/doi/pdf/10.2217/pme-2016-0052Citation Count: 7
-
OPENTitle: Promoting Physical Activity Among Immigrant Asian Americans: Results from Four Community Health Worker StudiesJournal Name: Journal of Immigrant and Minority HealthPublisher: Springer Science and Business Media LLCVol: 25Issue #: 2Start Page: 291End Page: 305Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s10903-022-01411-yBest OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/11520280Citation Count: 4
- PPMI 2.O New Science/New Cohorts - Transforming PPMI (2490)2020RESTRICTEDTitle: PPMI 2.O New Science/New Cohorts - Transforming PPMI (2490)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 94Issue #: 15_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.94.15_supplement.2490Citation Count: 7
- Human Peripheral Blood Neutrophil Isolation for Interrogating the Parkinson's Associated LRRK2 Kinase Pathway by Assessing Rab10 Phosphorylation2020RESTRICTEDTitle: Human Peripheral Blood Neutrophil Isolation for Interrogating the Parkinson's Associated LRRK2 Kinase Pathway by Assessing Rab10 PhosphorylationJournal Name: Journal of Visualized ExperimentsPublisher: MyJove CorporationVol:Issue #: 157Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.3791/58956-vCitation Count: 6
- How PPMI Enabled the First Interventional Platform Trial to Test Therapies in Participants With Early‐Stage Neuronal Alpha‐Synuclein Disease2026RESTRICTEDTitle: How PPMI Enabled the First Interventional Platform Trial to Test Therapies in Participants With Early‐Stage Neuronal Alpha‐Synuclein DiseaseJournal Name: Annals of NeurologyPublisher: WileyVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/ana.78250Citation Count: 0
- The Promise and Pitfalls of Facebook Advertising: a Genetic Counselor's Perspective2018RESTRICTEDTitle: The Promise and Pitfalls of Facebook Advertising: a Genetic Counselor's PerspectiveJournal Name: Journal of Genetic CounselingPublisher: WileyVol: 27Issue #: 2Start Page: 326End Page: 328Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s10897-017-0207-3Citation Count: 5
-
OPENTitle: The Michael J. Fox Foundation's quest for a cure for Parkinson's disease: an interview with Nicole PolinskiJournal Name: Disease Models & MechanismsPublisher: The Company of BiologistsVol: 16Issue #: 12Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1242/dmm.050605Best OA location URL: https://journals.biologists.com/dmm/article-pdf/16/12/dmm050605/3311458/dmm050605.pdfCitation Count: 0
-
OPENTitle: Effects of LRRK2 Inhibitors on Nigrostriatal Dopaminergic NeurotransmissionJournal Name: CNS Neuroscience & TherapeuticsPublisher: WileyVol: 23Issue #: 2Start Page: 162End Page: 173Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1111/cns.12660Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/cns.12660Citation Count: 31
-
OPENTitle: Assessment of myocardial sympathetic innervation with [123I]mIBG myocardial scintigraphy: A comparative study between an Anger and a ring-configured cadmium-zinc-telluride gamma cameraJournal Name: Journal of Nuclear CardiologyPublisher: Elsevier BVVol: 56Issue #:Start Page: 102574End Page: 102574Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.nuclcard.2025.102574Best OA location URL: https://doi.org/10.1016/j.nuclcard.2025.102574Citation Count: 0
-
OPENTitle: Radiolabeled Aminopyrazoles as Novel Isoform Selective Probes for pJNK3 QuantificationJournal Name: ACS Medicinal Chemistry LettersPublisher: American Chemical Society (ACS)Vol: 13Issue #: 10Start Page: 1606End Page: 1614Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acsmedchemlett.2c00278Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9575163Citation Count: 4
-
OPENTitle: Treatment response to onabotulinumtoxinA in cervical dystonia patients with anterocollis and retrocollisJournal Name: ToxiconPublisher: Elsevier BVVol: 248Issue #:Start Page: 108035End Page: 108035Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.toxicon.2024.108035Best OA location URL: https://doi.org/10.1016/j.toxicon.2024.108035Citation Count: 4
-
OPENTitle: Constipation in a Large Online Cohort of Persons with Parkinson's DiseaseJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 12Issue #: 12Start Page: 2232End Page: 2246Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.70168Best OA location URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC12715370/Citation Count: 2
- Application of the movement disorder society prodromal Parkinson's disease research criteria in 2 independent prospective cohorts2017RESTRICTEDTitle: Application of the movement disorder society prodromal Parkinson's disease research criteria in 2 independent prospective cohortsJournal Name: Movement DisordersPublisher: WileyVol: 32Issue #: 7Start Page: 1025End Page: 1034Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.27035Citation Count: 97
-
OPENTitle: Regulation of expression quantitative trait loci by SVA retrotransposons within the major histocompatibility complexJournal Name: Experimental Biology and MedicinePublisher: Frontiers Media SAVol:Issue #:Start Page: 2304End Page: 2318Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1177/15353702231209411Best OA location URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC10903234/pdf/10.1177_15353702231209411.pdfCitation Count: 10
-
OPENTitle: Pharmacodynamic, pharmacokinetic and rat brain receptor occupancy profile of NLX-112, a highly selective 5-HT1A receptor biased agonistJournal Name: Naunyn-Schmiedeberg's Archives of PharmacologyPublisher: Springer Science and Business Media LLCVol: 398Issue #: 1Start Page: 991End Page: 1002Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s00210-024-03323-0Best OA location URL: https://hal.science/hal-04932477/documentCitation Count: 1
-
OPENTitle: Generation of RAB39B knockout isogenic human embryonic stem cell lines to model RAB39B-mediated Parkinson's diseaseJournal Name: Stem Cell ResearchPublisher: Elsevier BVVol: 28Issue #:Start Page: 161End Page: 164Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.scr.2018.02.015Best OA location URL: https://doi.org/10.1016/j.scr.2018.02.015Citation Count: 9
-
OPENTitle: Distinct Roles of the Human Subthalamic Nucleus and Dorsal Pallidum in Parkinson’s Disease ImpulsivityJournal Name: Biological PsychiatryPublisher: Elsevier BVVol: 91Issue #: 4Start Page: 370End Page: 379Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.biopsych.2021.03.002Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8419208Citation Count: 14
- Normal and pathological neuronal distribution of the human mesencephalic locomotor region2018RESTRICTEDTitle: Normal and pathological neuronal distribution of the human mesencephalic locomotor regionJournal Name: Movement DisordersPublisher: WileyVol: 34Issue #: 2Start Page: 218End Page: 227Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.27578Citation Count: 37
- Reply To: Detection of Alpha‐Synuclein in Saliva: The Importance of Preanalytical Assessment2018RESTRICTEDTitle: Reply To: Detection of Alpha‐Synuclein in Saliva: The Importance of Preanalytical AssessmentJournal Name: Movement DisordersPublisher: WileyVol: 33Issue #: 6Start Page: 1031End Page: 1031Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.27424Citation Count: 1
- Endogenous 2-oxoglutarate levels impact potencies of competitive HIF prolyl hydroxylase inhibitors2011RESTRICTEDTitle: Endogenous 2-oxoglutarate levels impact potencies of competitive HIF prolyl hydroxylase inhibitorsJournal Name: Pharmacological ResearchPublisher: Elsevier BVVol: 64Issue #: 3Start Page: 268End Page: 273Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.phrs.2011.03.017Citation Count: 54
- Modelling cognitive deficits in Parkinson's disease: Is CA2 a gateway for hippocampal synucleinopathy?2020RESTRICTEDTitle: Modelling cognitive deficits in Parkinson's disease: Is CA2 a gateway for hippocampal synucleinopathy?Journal Name: Experimental NeurologyPublisher: Elsevier BVVol: 330Issue #:Start Page: 113357End Page: 113357Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.expneurol.2020.113357Citation Count: 21
-
RESTRICTEDTitle: Estimation of genetic risk function with covariates in the presence of missing genotypesJournal Name: Statistics in MedicinePublisher: WileyVol: 36Issue #: 22Start Page: 3533End Page: 3546Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/sim.7376Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5583003Citation Count: 4
-
OPENTitle: Increased expression of the dopamine transporter leads to loss of dopamine neurons, oxidative stress and l-DOPA reversible motor deficitsJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 74Issue #:Start Page: 66End Page: 75Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2014.10.016Best OA location URL: http://doi.org/10.1016/j.nbd.2014.10.016Citation Count: 160
-
OPENTitle: CSF Aβ42 and tau in Parkinson's disease with cognitive impairmentJournal Name: Movement DisordersPublisher: WileyVol: 25Issue #: 15Start Page: 2682End Page: 2685Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.23287Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/2978754Citation Count: 181
-
OPENTitle: Patient Perceptions on a Wearable Sensor Technology for Swallowing: A Qualitative Study with Patients with Parkinson’s DiseaseJournal Name: DysphagiaPublisher: Springer Science and Business Media LLCVol: 41Issue #: 3Start Page: 573End Page: 584Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s00455-025-10910-7Best OA location URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC13172249/Citation Count: 1
- Chelerythrine promotes Ca2+-dependent calpain activation in neuronal cells in a PKC-independent manner2017RESTRICTEDTitle: Chelerythrine promotes Ca2+-dependent calpain activation in neuronal cells in a PKC-independent mannerJournal Name: Biochimica et Biophysica Acta (BBA) - General SubjectsPublisher: Elsevier BVVol: 1861Issue #: 4Start Page: 922End Page: 935Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.bbagen.2017.01.021Citation Count: 18
-
OPENTitle: M1 Muscarinic Receptors Modulate Fear-Related Inputs to the Prefrontal Cortex: Implications for Novel Treatments of Posttraumatic Stress DisorderJournal Name: Biological PsychiatryPublisher: Elsevier BVVol: 85Issue #: 12Start Page: 989End Page: 1000Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.biopsych.2019.02.020Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6555658Citation Count: 35
-
OPENTitle: Disruption of the LRRK2‐FADD Interface Using Constrained PeptidesJournal Name: Peptide SciencePublisher: WileyVol: 116Issue #: 6Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/pep2.24374Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/pep2.24374Citation Count: 3